Mounjaro Injection and Alcohol: UK Safety Guidelines Written by Bolt Pharmacy Published 27/10/2025 Last Updated 29/7/2026 Mounjaro (tirzepatide) is a once-weekly injectable medication licensed in the UK for type 2 diabetes mellitus, and as Zepbound for weight management in adults with obesity. Many patients wonder whether it is safe to drink alcohol whilst taking Mounjaro […]
Tag Archives: Mounjaro safety tips
Mounjaro and Coffee: Weight Loss Compatibility and Safety Written by Bolt Pharmacy Published 6/11/2025 Last Updated 16/4/2026 Many people prescribed Mounjaro (tirzepatide) for weight management wonder whether their daily coffee habit is compatible with treatment. Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for chronic weight management in adults with […]
Mounjaro in the Arm: Safe Injection Sites and Technique Written by Bolt Pharmacy Published 5/11/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus, administered via once-weekly subcutaneous injection. Many patients wonder whether Mounjaro can be injected in the arm, particularly if […]
Does Mounjaro Cause Fever? UK Clinical Guidance Written by Bolt Pharmacy Published 31/10/2025 Last Updated 16/4/2026 Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus. Patients and clinicians often ask: does Mounjaro cause fever? Fever is not listed as a common side effect in the […]
Loopy Off the Mounjaro: Causes, Safety, and Management Written by Bolt Pharmacy Published 6/11/2025 Last Updated 16/4/2026 Feeling ‘loopy’ on Mounjaro (tirzepatide) is a colloquial term some patients use to describe dizziness, light-headedness, mental fog, or disorientation during treatment. Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 […]
Does Mounjaro Make You Sad? Mood Effects Explained Written by Bolt Pharmacy Published on 3/7/2026 Does Mounjaro make you sad? This question concerns many patients starting tirzepatide treatment for type 2 diabetes or weight management in the UK. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed by the MHRA, with common side effects primarily […]